Position in XNCR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,002,324
+$451,915 QoQ
Shares Held
124,368
-3.3% QoQ
Ownership
0.167%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#52
of 208 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 97%
None 3%
Common Shares in XNCR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AMERIPRISE FINANCIAL INC holds $5,025,615,702 across 202 Biotechnology names. XNCR ranks #131 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,604,822 | $1,293,893,227 | |
| 2 | INSM |
INSMED Inc
|
6,179,571 | $658,865,856 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,215,523 | $292,904,576 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
1,039,702 | $194,715,388 | |
| 5 | ARGX |
Argenx SE
|
181,464 | $168,356,853 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
227,457 | $141,828,535 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
231,205 | $124,145,521 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,551,663 | $115,567,858 |
All Filings in XNCR
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,002,324 | 124,368 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,550,409 | 128,558 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,079,189 | 135,806 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,720,591 | 146,683 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $2,474,744 | 314,853 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,287,313 | 308,958 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $6,723,396 | 292,576 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $3,412,786 | 169,706 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $3,635,335 | 192,041 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $5,087,154 | 229,876 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $5,399,850 | 254,350 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $7,078,008 | 351,266 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $9,465,151 | 379,061 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $10,797,445 | 387,144 | Shares | Defined | 2023-05-22 | |
| 2022-12-31 | $10,265,904 | 394,236 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $9,728,417 | 374,458 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $7,757,669 | 283,437 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $7,314,881 | 274,171 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $10,653,784 | 265,548 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $8,568,840 | 262,365 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $9,291,226 | 269,389 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $12,326,268 | 286,258 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $12,680,753 | 290,643 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $12,358,531 | 318,601 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $9,529,687 | 294,217 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $7,675,126 | 256,865 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||